Show simple item record

dc.contributor.authorSimmonds, M
dc.contributor.authorThamsen, B
dc.contributor.authorKertzscher, U
dc.description.abstractAdvancements in both the design of mechanical circulatory support (MCS) and medical care for recipients have led to steady improvements in patient survival over the last decades. Indeed, current generations of ventricular assist devices (VADs), for example, provide important therapeutic alternatives for individuals with heart failure that may be ineligible for heart transplant. Nevertheless, it is clear that freedom from adverse events (including premature death) is experienced by an unacceptably low proportion of MCS recipients, as evidenced by recent INTERMACS reports.1 The primary complications observed post surgery remain neurological disorders (e.g. stroke), multi-system organ failure and infection. While infection remains an ongoing area of interest with important advancement, it is currently being explored whether a common aetiology may explain the high rate of organ failure (including the brain).
dc.publisherSage Publications
dc.publisher.placeUnited Kingdom
dc.relation.ispartofjournalInternational Journal of Artificial Organs
dc.subject.fieldofresearchBiomedical Engineering
dc.titleBlood damage in ventricular assist devices
dc.typeJournal article
dc.type.descriptionC2 - Articles (Other)
dcterms.bibliographicCitationSimmonds, M; Thamsen, B; Kertzscher, U, Blood damage in ventricular assist devices, International Journal of Artificial Organs, 2019, 42 (3), pp. 111-112
gro.hasfulltextNo Full Text
gro.griffith.authorSimmonds, Michael J.

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record